Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01051479 · ClinicalTrials.gov registry record · Phase 1
A Pilot C11-Choline PET-CT Imaging Study in Patients With Locally Advanced Esophageal Cancer
A Phase 1 study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Phase 1
- Development phase
- 22
- Enrollment target
NCT01051479 is a Phase 1 study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 22 participants.
The verdict
NCT01051479, a Phase 1 study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the investigators ability to obtain reliable and meaningful 11C-Choline PET-CT images of esophageal cancer.
Interventions
- DRUG C11-Choline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2010-03 |
| Est. Completion | 2013-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01051479
The ClinicalTrials.gov registry entry for NCT01051479 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which C11-Choline is the first listed.
NCT01051479 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01051479 about?
NCT01051479 is a clinical study titled "A Pilot C11-Choline PET-CT Imaging Study in Patients With Locally Advanced Esophageal Cancer". The purpose of this study is to evaluate the investigators ability to obtain reliable and meaningful 11C-Choline PET-CT images of esophageal cancer.
What is the current status of trial NCT01051479?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 22 participants. The study started on 2010-03. Estimated completion is 2013-08.
What interventions are being tested in trial NCT01051479?
The interventions under investigation include: C11-Choline (DRUG).
Who is sponsoring clinical trial NCT01051479?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.